Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic study of stable tacrolimus dose in Han Chinese renal transplant recipients
ChiCTR-RNC-12002894Phase 4Completed
- Sponsor
- Central South University
- Start
- Oct 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in kidney transplant, sponsored by Central South University. Primary endpoint: Tacrolimus blood concentration. Started Oct 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on ChiCTR-RNC-12002894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RNC-12002894.